High-Intensity Focused Ultrasound (HIFU) Treatment for Prostate Cancer: HIFU Treatment for Prostate Cancer

Rüştü Türkay

doi:10.70087/rami.tui/010108

Yazarlar

Doç Dr Rüştü Türkay Radiology Author https://orcid.org/0000-0002-7837-9861

DOI:

https://doi.org/10.70087/rami.tui/010108

Anahtar Kelimeler:

prostat kanseri- prostat görüntüleme- HIFU

Öz

Yüksek Yoğunluklu Odaklanmış Ultrason (HIFU), prostat kanseri için yeni ortaya çıkan minimal invazif bir tedavi yöntemini temsil eder. Bu teknoloji, prostat dokusunu yok etmek için odaklanmış ultrason dalgaları kullanır ve lokalize prostat kanserinin yönetimi için kesin ve hedefe yönelik bir strateji sunar. Bu makale, teknolojisini, avantajlarını, risklerini, hasta seçim kriterlerini ve tedavi sonrası izlemeyi kapsayan HIFU’nun kapsamlı bir incelemesini sunmayı amaçlamaktadır.

İndirmeler

İndirme verisi henüz mevcut değil.

Referanslar

American Cancer Society. Key Statistics for Prostate Cancer. https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics. Published 2020. Updated daily. Accessed January 19, 2024.

Gelet A, Chapelon JY, Bouvier R, Souchon R, Pangaud C, Abdelrahim AF, et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol. 1996;29(2):174-83.

Hopstaken JS, Bomers JGR, Sedelaar MJP, Valerio M, Fütterer JJ, Rovers MM. An updated systematic review on focal therapy in localized prostate cancer: What has changed over the past 5 years? Eur Urol. 2022 Jan;81(1):5-33. doi: 10.1016/j.eururo.2021.08.005.

Uchida T, Sanghvi NT, Gardner TA, Koch MO, Ishii D, Minei S, et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. Urology. 2002 Mar;59(3):394-398; discussion 398-9. doi: 10.1016/s0090-4295(01)01624-7.

Ganzer R, Arthanareeswaran VKA, Ahmed HU, Cestari A, Rischmann P, Salomon G, et al. Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement. Prostate Cancer Prostatic Dis. 2018 Jun;21(2):175-86. doi: 10.1038/s41391-018-0042-0.

Crouzet S, Chapelon JY, Rouvière O, Mege-Lechevallier F, Colombel M, Tonoli-Catez H, et al. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Eur Urol. 2014 May;65(5):907-14. doi: 0.1016/j.eururo.2013.04.039.

Rebillard X, Gelet A, Davin JL, Soulie M, Prapotnich D, Cathelineau X, Rozet F, Vallancien G. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer. J Endourol. 2005 JulAug;19(6):693-701. doi: 10.1089/end.2005.19.693.

Ghai S, Finelli A, Corr K, Chan R, Jokhu S, Li X, et al. MRI-guided focused ultrasound ablation for localized intermediate-risk prostate cancer: Early results of a phase II trial. Radiology. 2021 Mar;298(3):695-703. doi: 10.1148/radiol.2021202717.

Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. PROMIS study group. Diagnostic accuracy of multiparametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017 Feb 25;389(10071):815-22. doi: 10.1016/S0140-6736(16)32401-1.

Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.JAMA. 2015 Jan 27;313(4):390-7. doi: 10.1001/jama.2014.17942.

Bakavicius A, Marra G, Macek P, Robertson C, Abreu AL, George AK, et al. Available evidence on HIFU for focal treatment of prostate cancer: a systematic review. Int Braz J Urol. 2022 Mar-Apr;48(2):263-74. doi: 10.1590/S1677-5538.IBJU.2021.0091.

Napoli A, Alfieri G, Scipione R, Leonardi A, Fierro D, Panebianco V, et al. High-intensity focused ultrasound for prostate cancer. Expert Rev Med Devices. 2020 May;17(5):427-33. doi: 10.1080/17434440.2020.1755258.

Chapelon JY, Rouvière O, Crouzet S, Gelet A. Prostate-focused ultrasound therapy. Adv Exp Med Biol. 2016;880:21-41. doi: 10.1007/978-3-319-22536-4_2.

Rébillard X, Davin JL, Soulié M; Comité de Cancérologie de l’Association Française d’Urologie. Traitement par HIFU du cancer de la prostate: revue de la littérature et indications de traitement [Treatment by HIFU of prostate cancer: survey of literature and treatment indications]. Prog Urol. 2003 Dec;13(6):1428-56.

Turkbey B, Pinto PA, Choyke PL. Imaging techniques for prostate cancer: implications for focal therapy. Nat Rev Urol. 2009 Apr;6(4):191- 203. doi: 10.1038/nrurol.2009.27.

Ziglioli F, Baciarello M, Maspero G, Bellini V, Bocchialini T, Cavalieri D, et al. Oncologic outcome, side effects and comorbidity of high-intensity focused ultrasound (HIFU) for localized prostate cancer. A review. Ann Med Surg (Lond). 2020 May 30;56:110-5. doi: 10.1016/j.amsu.2020.05.029.

Ayerra Perez H, Barba Abad JF, Extramiana Cameno J. An update on focal therapy for prostate cancer. Clin Genitourin Cancer. 2023 Dec;21(6):712.e1-712.e8. doi: 10.1016/j.clgc.2023.04.013.

Siedek F, Yeo SY, Heijman E, Grinstein O, Bratke G, Heneweer C, et al. Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU): Technical background and overview of current clinical applications (Part 1). Rofo. 2019 Jun;191(6):522-30. English. doi: 10.1055/a-0817-5645.

Duwe G, Boehm K, Haack M, Sparwasser P, Brandt MP, Mager R, et al. Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected. World J Urol. 2023 May;41(5):1293-9. doi: 10.1007/s00345-023-04352-9.

Hectors SJ, Jacobs I, Moonen CT, Strijkers GJ, Nicolay K. MRI methods for the evaluation of high-intensity focused ultrasound tumor treatment: Current status and future needs. Magn Reson Med. 2016 Jan;75(1):302-7. doi: 10.1002/mrm.25758.

Khandwala YS, Morisetty S, Ghanouni P, Fan RE, Soerensen SJC, Rusu M, et al. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation. Urol Oncol. 2022 Nov;40(11):489.e9-489.e17. doi: 10.1016/j.urolonc.2022.07.017.

Apfelbeck M, Chaloupka M, Schlenker B, Stief CG, Clevert DA. Follow-up after focal therapy of the prostate with high-intensity focused ultrasound (HIFU) using contrast-enhanced ultrasound (CEUS) in combination with MRI image fusion. Clin Hemorheol Microcirc. 2019;73(1):135-43. doi: 10.3233/CH-199222.

Bründl J, Osberghaus V, Zeman F, Breyer J, Ganzer R, Blana A, et al. Oncological long-term outcome after whole-gland high-intensity focused ultrasound for prostate cancer-21-yr follow-up. Eur Urol Focus. 2022 Jan;8(1):134-40. doi: 10.1016/j.euf.2020.12.016.

Rouvière O, Gelet A, Crouzet S, Chapelon JY. Prostate focused ultrasound focal therapy--imaging for the future. Nat Rev Clin Oncol. 2012 Dec;9(12):721-7. doi: 10.1038/nrclinonc.2012.136.

Chen FK, de Castro Abreu AL, Palmer SL. Utility of ultrasound in the diagnosis, treatment, and follow-up of prostate cancer: State of the art. J Nucl Med. 2016 Oct;57(Suppl 3):13S-18S. doi: 10.2967/jnumed.116.177196.